ScreenerHero
XGNExagen Inc.
NAS · US · Healthcare · Diagnostics & Research · exagen.com
4.650USD+0.22%Mkt Cap: 112.34M $P/E: —

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and m…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Pricier
1M Perf
Higher
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
RVTY
Revvity, Inc.
$12.41BUSDP/E 53.5
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
RDNT
RadNet, Inc.
$4.85BUSD
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CDNA
CareDx, Inc.
$1.47BUSD
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
MYGN
Myriad Genetics, Inc.
$539.30MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
BIOPOR
BioPorto A/S
$77.88MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
IMMNOV
Immunovia AB (publ)
$12.55MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap112.34M $
Enterprise Value118.22M $
Revenue (TTM)68.38M $
Gross Profit38.80M $
Net Income (TTM)-19.95M $
Revenue/Share2.988 USD
Last Price4.650 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees216
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS30068X1037
Valuation
P/E (Trailing)—
P/E (Forward)-10.81
PEG—
EV/EBITDA-9.98
EV/Revenue1.73
P/S1.64
P/B7.76
EPS (TTM)-0.90
EPS (Forward)-0.43
52W Range
2.59021% of range12.23
52W High12.23 USD
52W Low2.590 USD
Profitability
Gross Margin58.28%
Oper. Margin-19.73%
EBITDA Margin-17.32%
Profit Margin-29.97%
ROE-114.34%
ROA-34.39%
Growth
Revenue Growth11.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.63M $
CapEx (TTM)641.00K $
FCF Margin-13.26%
FCF Yield-8.07%
Net Debt5.63M $
Net Debt/EBITDA-0.48
Balance Sheet
Debt/Equity1.47
Current Ratio3.47
Quick Ratio2.97
Book Value/Sh0.5990 USD
Cash/Share0.8900 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.571 USD
Upside (mean)+84.3%
Target Range8.000 USD – 10.00 USD
$8.000+84.3% to mean$10.00
# Analysts7
Ownership
Shares Out.24.16M
Float13.81M
Insiders27.91%
Institutions52.64%
Short Interest
Short Ratio1.6d
Short % Float2.89%
Short % Out.2.62%
Shares Short633.37K
Short (prev mo.)716.15K
Technical
SMA 503.906 (+19.0%)
SMA 2005.938 (-21.7%)
Beta2.02
S&P 52W Chg20.05%
Avg Vol (30d)321.24K
Avg Vol (10d)235.46K
Technical Indicators
RSI (14)56.2
MACD0.1477
MACD Signal0.1825
MACD Hist.-0.0348
BB Upper5.129 USD
BB Middle4.556 USD
BB Lower3.983 USD
BB Width25.16%
ATR (14)0.3516 USD
Vol Ratio (20d)0.68x